Correlation Between Climb Bio and Renovaro Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Climb Bio and Renovaro Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Climb Bio and Renovaro Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Climb Bio and Renovaro Biosciences, you can compare the effects of market volatilities on Climb Bio and Renovaro Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Climb Bio with a short position of Renovaro Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Climb Bio and Renovaro Biosciences.

Diversification Opportunities for Climb Bio and Renovaro Biosciences

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Climb and Renovaro is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Climb Bio and Renovaro Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Renovaro Biosciences and Climb Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Climb Bio are associated (or correlated) with Renovaro Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Renovaro Biosciences has no effect on the direction of Climb Bio i.e., Climb Bio and Renovaro Biosciences go up and down completely randomly.

Pair Corralation between Climb Bio and Renovaro Biosciences

Given the investment horizon of 90 days Climb Bio is expected to generate 0.74 times more return on investment than Renovaro Biosciences. However, Climb Bio is 1.35 times less risky than Renovaro Biosciences. It trades about 0.11 of its potential returns per unit of risk. Renovaro Biosciences is currently generating about -0.13 per unit of risk. If you would invest  140.00  in Climb Bio on June 13, 2025 and sell it today you would earn a total of  98.00  from holding Climb Bio or generate 70.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Climb Bio  vs.  Renovaro Biosciences

 Performance 
       Timeline  
Climb Bio 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Climb Bio are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, Climb Bio displayed solid returns over the last few months and may actually be approaching a breakup point.
Renovaro Biosciences 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Renovaro Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in October 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Climb Bio and Renovaro Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Climb Bio and Renovaro Biosciences

The main advantage of trading using opposite Climb Bio and Renovaro Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Climb Bio position performs unexpectedly, Renovaro Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Renovaro Biosciences will offset losses from the drop in Renovaro Biosciences' long position.
The idea behind Climb Bio and Renovaro Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated